-
1
-
-
0035467993
-
Global cancer statistics in the year 2000
-
Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2 (2001) 533-543
-
(2001)
Lancet Oncol
, vol.2
, pp. 533-543
-
-
Parkin, D.M.1
-
2
-
-
33847276516
-
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
-
Ohe Y., Ohashi Y., Kubota K., et al. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 18 (2007) 317-323
-
(2007)
Ann Oncol
, vol.18
, pp. 317-323
-
-
Ohe, Y.1
Ohashi, Y.2
Kubota, K.3
-
3
-
-
2342471392
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
-
Lynch T.J., Bell D.W., Sordella R., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 (2004) 2129-2139
-
(2004)
N Engl J Med
, vol.350
, pp. 2129-2139
-
-
Lynch, T.J.1
Bell, D.W.2
Sordella, R.3
-
4
-
-
2342624080
-
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy
-
Paez J.G., Janne P.A., Lee J.C., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
-
(2004)
Science
, vol.304
, pp. 1497-1500
-
-
Paez, J.G.1
Janne, P.A.2
Lee, J.C.3
-
5
-
-
4444344330
-
EGF receptor gene mutations are common in lung cancer from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
-
Pao W., Miller V., Zakowski M., et al. EGF receptor gene mutations are common in lung cancer from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101 (2004) 13306-13311
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 13306-13311
-
-
Pao, W.1
Miller, V.2
Zakowski, M.3
-
6
-
-
33846202907
-
Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs
-
Ono M., and Kuwano M. Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs. Clin Cancer Res 12 (2006) 7242-7251
-
(2006)
Clin Cancer Res
, vol.12
, pp. 7242-7251
-
-
Ono, M.1
Kuwano, M.2
-
7
-
-
20044364940
-
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
-
Shigematsu H., Lin L., Takahashi T., et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97 (2005) 339-346
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 339-346
-
-
Shigematsu, H.1
Lin, L.2
Takahashi, T.3
-
8
-
-
69949162760
-
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
-
Mok T.S., Wu Y.L., Thongprasert S., et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361 (2009) 947-957
-
(2009)
N Engl J Med
, vol.361
, pp. 947-957
-
-
Mok, T.S.1
Wu, Y.L.2
Thongprasert, S.3
-
9
-
-
4444339833
-
Oxidative DNA damage and disease: induction, repair and significance
-
Evans M.D., Dizdaroglu M., and Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567 (2004) 1-61
-
(2004)
Mutat Res
, vol.567
, pp. 1-61
-
-
Evans, M.D.1
Dizdaroglu, M.2
Cooke, M.S.3
-
10
-
-
34147174320
-
Significance of error-avoiding mechanisms for oxidative DNA damage in carcinogenesis
-
Tsuzuki T., Nakatsu Y., and Nakabeppu Y. Significance of error-avoiding mechanisms for oxidative DNA damage in carcinogenesis. Cancer Sci 98 (2007) 465-470
-
(2007)
Cancer Sci
, vol.98
, pp. 465-470
-
-
Tsuzuki, T.1
Nakatsu, Y.2
Nakabeppu, Y.3
-
11
-
-
38549153790
-
Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs
-
Oka S., Ohno M., Tsuchimoto D., Sakumi K., Furuichi M., and Nakabeppu Y. Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs. EMBO J 27 (2008) 421-432
-
(2008)
EMBO J
, vol.27
, pp. 421-432
-
-
Oka, S.1
Ohno, M.2
Tsuchimoto, D.3
Sakumi, K.4
Furuichi, M.5
Nakabeppu, Y.6
-
12
-
-
0037374556
-
Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption
-
Sakumi K., Tominaga Y., Furuichi M., et al. Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption. Cancer Res 63 (2003) 902-905
-
(2003)
Cancer Res
, vol.63
, pp. 902-905
-
-
Sakumi, K.1
Tominaga, Y.2
Furuichi, M.3
-
13
-
-
3042739635
-
Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 DNA glycosylases
-
Russo M.T., De Luca G., Degan P., et al. Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 DNA glycosylases. Cancer Res 64 (2004) 4411-4414
-
(2004)
Cancer Res
, vol.64
, pp. 4411-4414
-
-
Russo, M.T.1
De Luca, G.2
Degan, P.3
-
14
-
-
0032508052
-
Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours
-
Chevillard S., Radicella J.P., Levalois C., et al. Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours. Oncogene 16 (1998) 3083-3086
-
(1998)
Oncogene
, vol.16
, pp. 3083-3086
-
-
Chevillard, S.1
Radicella, J.P.2
Levalois, C.3
-
15
-
-
27744531188
-
Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review
-
Hung R.J., Hall J., Brennan P., and Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162 (2005) 925-942
-
(2005)
Am J Epidemiol
, vol.162
, pp. 925-942
-
-
Hung, R.J.1
Hall, J.2
Brennan, P.3
Boffetta, P.4
-
16
-
-
12444255113
-
Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers
-
Chiou C.C., Chang P.Y., Chan E.C., Wu T.L., Tsao K.C., and Wu J.T. Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin Chim Acta 334 (2003) 87-94
-
(2003)
Clin Chim Acta
, vol.334
, pp. 87-94
-
-
Chiou, C.C.1
Chang, P.Y.2
Chan, E.C.3
Wu, T.L.4
Tsao, K.C.5
Wu, J.T.6
-
17
-
-
34548292501
-
Base excision repair modulation as a risk factor for human cancers
-
Tudek B. Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med 28 (2007) 258-275
-
(2007)
Mol Aspects Med
, vol.28
, pp. 258-275
-
-
Tudek, B.1
-
18
-
-
33749317535
-
8-Hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures
-
Pilger A., and Rüdiger H.W. 8-Hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. Int Arch Occup Environ Health 80 (2006) 1-15
-
(2006)
Int Arch Occup Environ Health
, vol.80
, pp. 1-15
-
-
Pilger, A.1
Rüdiger, H.W.2
-
19
-
-
61749096817
-
Biomarkers of oxidative stress and damage in human populations exposed to arsenic
-
De Vizcaya-Ruiz A., Barbier O., Ruiz-Ramos R., and Cebrian M.E. Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat Res 674 (2009) 85-92
-
(2009)
Mutat Res
, vol.674
, pp. 85-92
-
-
De Vizcaya-Ruiz, A.1
Barbier, O.2
Ruiz-Ramos, R.3
Cebrian, M.E.4
-
20
-
-
0032147094
-
Gene regulation by Y-box proteins: coupling control of transcription and translation
-
Matsumoto K., and Wolffe A.P. Gene regulation by Y-box proteins: coupling control of transcription and translation. Trends Cell Biol 8 (1998) 318-323
-
(1998)
Trends Cell Biol
, vol.8
, pp. 318-323
-
-
Matsumoto, K.1
Wolffe, A.P.2
-
21
-
-
0037829212
-
The pleiotropic functions of the Y-box-binding protein, YB-1
-
Kohno K., Izumi H., Uchiumi T., et al. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25 (2003) 691-698
-
(2003)
Bioessays
, vol.25
, pp. 691-698
-
-
Kohno, K.1
Izumi, H.2
Uchiumi, T.3
-
22
-
-
20144368814
-
YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification
-
Bergmann S., Royer-Pokara B., Fietze E., et al. YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res 65 (2005) 4078-4087
-
(2005)
Cancer Res
, vol.65
, pp. 4078-4087
-
-
Bergmann, S.1
Royer-Pokara, B.2
Fietze, E.3
-
23
-
-
67349125744
-
Novel DNA mismatch-repair activity involving YB-1 in human mitochondria
-
de Souza-Pinto N., Mason P., Hashiguchi K., et al. Novel DNA mismatch-repair activity involving YB-1 in human mitochondria. DNA Repair 8 (2009) 704-719
-
(2009)
DNA Repair
, vol.8
, pp. 704-719
-
-
de Souza-Pinto, N.1
Mason, P.2
Hashiguchi, K.3
-
24
-
-
0344820727
-
Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen
-
Ise T., Nagatani G., Imamura T., et al. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res 59 (1999) 342-346
-
(1999)
Cancer Res
, vol.59
, pp. 342-346
-
-
Ise, T.1
Nagatani, G.2
Imamura, T.3
-
25
-
-
0037159257
-
Binding capacity of human YB-1 protein for RNA containing 8-oxoguanine
-
Hayakawa H., Uchiumi T., Fukuda T., et al. Binding capacity of human YB-1 protein for RNA containing 8-oxoguanine. Biochemistry 41 (2002) 12739-12744
-
(2002)
Biochemistry
, vol.41
, pp. 12739-12744
-
-
Hayakawa, H.1
Uchiumi, T.2
Fukuda, T.3
-
26
-
-
0034796873
-
Nuclear expression of the Y-box binding protein as a novel marker of disease progression in non-small cell lung cancer
-
Shibahara K., Sugio K., Osaki T., et al. Nuclear expression of the Y-box binding protein as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res 7 (2001) 3151-3155
-
(2001)
Clin Cancer Res
, vol.7
, pp. 3151-3155
-
-
Shibahara, K.1
Sugio, K.2
Osaki, T.3
-
27
-
-
69549091683
-
Nuclear Y-box binding protein-1 (YB-1), a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer
-
Kashihara M., Azuma K., Kawahara A., et al. Nuclear Y-box binding protein-1 (YB-1), a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer. J Thorac Oncol 4 (2009) 1066-1074
-
(2009)
J Thorac Oncol
, vol.4
, pp. 1066-1074
-
-
Kashihara, M.1
Azuma, K.2
Kawahara, A.3
-
28
-
-
33947502512
-
Lung cancer in never smokers: a review
-
Subramanian J., and Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 25 (2007) 561-570
-
(2007)
J Clin Oncol
, vol.25
, pp. 561-570
-
-
Subramanian, J.1
Govindan, R.2
-
29
-
-
38949169542
-
Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma
-
Toyooka S., Takano T., Kosaka T., et al. Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma. Cancer Sci 99 (2008) 303-308
-
(2008)
Cancer Sci
, vol.99
, pp. 303-308
-
-
Toyooka, S.1
Takano, T.2
Kosaka, T.3
-
30
-
-
0041438479
-
Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer
-
Gackowski D., Speina E., Zielinska M., et al. Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer. Cancer Res 63 (2003) 4899-4902
-
(2003)
Cancer Res
, vol.63
, pp. 4899-4902
-
-
Gackowski, D.1
Speina, E.2
Zielinska, M.3
-
31
-
-
0042832464
-
DNA repair activity for oxidative damage and risk of lung cancer
-
Paz-Elizur T., Krupsky M., Blumenstein S., Elinger D., Schechtman E., and Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 95 (2003) 1312-1319
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1312-1319
-
-
Paz-Elizur, T.1
Krupsky, M.2
Blumenstein, S.3
Elinger, D.4
Schechtman, E.5
Livneh, Z.6
-
32
-
-
0042090555
-
Decreased repair activities of 1, N6-ethenoadenine and 3, N4-ethenocytosine in lung adenocarcinoma patients
-
Speina E., Zielińska M., Barbin A., et al. Decreased repair activities of 1, N6-ethenoadenine and 3, N4-ethenocytosine in lung adenocarcinoma patients. Cancer Res 63 (2003) 4351-4357
-
(2003)
Cancer Res
, vol.63
, pp. 4351-4357
-
-
Speina, E.1
Zielińska, M.2
Barbin, A.3
-
33
-
-
9444259316
-
The role of nuclear Y-box binding protein 1 as a global marker in drug resistance
-
Kuwano M., Oda Y., Izumi H., et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. Mol Cancer Ther 3 (2004) 1485-1492
-
(2004)
Mol Cancer Ther
, vol.3
, pp. 1485-1492
-
-
Kuwano, M.1
Oda, Y.2
Izumi, H.3
-
34
-
-
1242342944
-
YB-1 promotes separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins
-
Gaudreaut I., Guay D., and Lebel M. YB-1 promotes separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins. Nucleic Acids Res 32 (2004) 316-327
-
(2004)
Nucleic Acids Res
, vol.32
, pp. 316-327
-
-
Gaudreaut, I.1
Guay, D.2
Lebel, M.3
-
35
-
-
35348971904
-
Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress
-
Das S., Chattopadhyay R., Bhakat K.K., et al. Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress. J Biol Chem 282 (2007) 28474-28484
-
(2007)
J Biol Chem
, vol.282
, pp. 28474-28484
-
-
Das, S.1
Chattopadhyay, R.2
Bhakat, K.K.3
|